Zions Bancorporation, National Association’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.3K Sell
753
-1,346
-64% -$111K ﹤0.01% 498
2025
Q4
$179K Buy
2,099
+1,122
+115% +$92.1K 0.01% 447
2025
Q3
$76K Buy
977
+26
+3% +$2.03K ﹤0.01% 494
2025
Q2
$74.4K Buy
951
+14
+1% +$1.04K ﹤0.01% 454
2025
Q1
$67.9K Buy
+937
New +$67.1K ﹤0.01% 447

Other funds holding EW

Zions Bancorporation, National Association's EW Position: Q1 2026 in Review

Zions Bancorporation, National Association reduced its Edwards Lifesciences (EW) stake by 64% in Q1 2026, selling an estimated $111K and leaving 753 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Zions Bancorporation, National Association first reported a position in EW in Q1 2025 and has held it in 5 quarters since. The position peaked at $179K in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Zions Bancorporation, National Association held 753 shares of Edwards Lifesciences worth $60.3K as of Q1 2026.
  • Zions Bancorporation, National Association sold 1,346 Edwards Lifesciences shares in Q1 2026, an estimated $111K.
  • Edwards Lifesciences made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #498 holding.
  • Zions Bancorporation, National Association first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 5 quarters since.
  • Zions Bancorporation, National Association's Edwards Lifesciences position peaked at $179K in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.